[Clinical evaluation of disodium cromoglycate with beta-2-agonist in therapy of patients with atopic bronchial asthma (preliminary study)].
In 38 patients with atopic bronchial asthma DNCG (disodium cromoglycate) and DNCG comp. (disodium cromoglycate and reproterol hydrochloride) were applied in inhalation way. After 7 days course spirometric values were monitoring in all patients. Decrease of Raw values and increases of FEF50 and FEV1 were noticed in all patients, especially in asthmatics treated with DNCG comp. Obtained results suggest a good clinical effect and improvement of spirometric values in patients with atopic bronchial asthma during DNCG and DNCG comp. therapy.
Płusa
T
T
II Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej, Warszawie.
Mamełka
B
B
Chciałowski
A
A
Włodarczyk
R
R
D000280:Administration, Inhalation; D000328:Adult; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000188:drug therapy*; D008297:Male; D009921:Metaproterenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D012129:Respiratory Function Tests; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use
D001993:Bronchodilator Agents; D004338:Drug Combinations; C014792:reproterol; D009921:Metaproterenol; D013806:Theophylline; D004205:Cromolyn Sodium
Ocena przydatności klinicznej kromoglikanu dwusodowego w połaczeniu z beta-2-agonista w leczeniu chorych na atopowa astme oskrzelowa (badania wstepne).